Skip to main content
. 2023 Oct 14;9(10):e21058. doi: 10.1016/j.heliyon.2023.e21058

Table 1.

Gene Expression values and Risk scores of samples of BLCA patients of our cohort.

Tumor Samples DLX1 DSC1 GNLY Risk Score Risk Group
T37 0.395464 0.399748 0.398755 0.14094403 Low Risk
T15 0.409501 0.427576 0.421973 0.14751408 Low Risk
T9 0.42662 0.411521 0.409563 0.15173857 Low Risk
T44 0.423999 0.43461 0.405816 0.1585099 Low Risk
T50 0.47725 0.477138 0.441988 0.17880091 Low Risk
T10 0.417016 0.429026 0.310101 0.17956884 High Risk
T52 0.499292 0.488207 0.458136 0.18501026 High Risk
T39 0.480964 0.475889 0.416388 0.18633474 High Risk
T14 0.483882 0.495983 0.424441 0.19098316 High Risk
T42 0.501269 0.52213 0.442059 0.1996277 High Risk